Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,025 | -4,374 | -4,251 | -2,430 | -1,670 |
| Depreciation Amortization | 15 | 14 | 13 | 0 | 0 |
| Accounts receivable | -23 | 12 | -9 | N/A | N/A |
| Other Working Capital | 2,666 | 783 | -367 | 780 | -20 |
| Other Operating Activity | 100 | -284 | 720 | 210 | 510 |
| Operating Cash Flow | $-1,266 | $-3,849 | $-3,895 | $-1,440 | $-1,180 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,013 | -464 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 110 | 160 |
| Investing Cash Flow | $N/A | $1,013 | $-464 | $110 | $160 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 411 | N/A | N/A | N/A | N/A |
| Debt Issued | -389 | N/A | 895 | N/A | N/A |
| Common Stock Issued | 1,152 | 2,352 | 3,627 | N/A | N/A |
| Other Financing Activity | 0 | -89 | -366 | 2,180 | 790 |
| Financing Cash Flow | $1,174 | $2,263 | $4,156 | $2,180 | $790 |
| Exchange Rate Effect | -44 | 10 | -53 | -30 | 10 |
| Beginning Cash Position | 157 | 709 | 993 | 130 | 350 |
| End Cash Position | 21 | 146 | 737 | 950 | 130 |
| Net Cash Flow | $-136 | $-563 | $-256 | $820 | $-220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,266 | -3,849 | -3,895 | -1,440 | -1,180 |
| Free Cash Flow | -1,266 | -3,849 | -3,895 | -1,440 | -1,180 |